Mansur, A.A.P.; Carvalho, S.M.; Oliveira, L.C.A.; Souza-Fagundes, E.M.; Lobato, Z.I.P.; Leite, M.F.; Mansur, H.S.
Bioengineered Carboxymethylcellulose–Peptide Hybrid Nanozyme Cascade for Targeted Intracellular Biocatalytic–Magnetothermal Therapy of Brain Cancer Cells. Pharmaceutics 2022, 14, 2223.
https://doi.org/10.3390/pharmaceutics14102223
AMA Style
Mansur AAP, Carvalho SM, Oliveira LCA, Souza-Fagundes EM, Lobato ZIP, Leite MF, Mansur HS.
Bioengineered Carboxymethylcellulose–Peptide Hybrid Nanozyme Cascade for Targeted Intracellular Biocatalytic–Magnetothermal Therapy of Brain Cancer Cells. Pharmaceutics. 2022; 14(10):2223.
https://doi.org/10.3390/pharmaceutics14102223
Chicago/Turabian Style
Mansur, Alexandra A. P., Sandhra M. Carvalho, Luiz Carlos A. Oliveira, Elaine Maria Souza-Fagundes, Zelia I. P. Lobato, Maria F. Leite, and Herman S. Mansur.
2022. "Bioengineered Carboxymethylcellulose–Peptide Hybrid Nanozyme Cascade for Targeted Intracellular Biocatalytic–Magnetothermal Therapy of Brain Cancer Cells" Pharmaceutics 14, no. 10: 2223.
https://doi.org/10.3390/pharmaceutics14102223
APA Style
Mansur, A. A. P., Carvalho, S. M., Oliveira, L. C. A., Souza-Fagundes, E. M., Lobato, Z. I. P., Leite, M. F., & Mansur, H. S.
(2022). Bioengineered Carboxymethylcellulose–Peptide Hybrid Nanozyme Cascade for Targeted Intracellular Biocatalytic–Magnetothermal Therapy of Brain Cancer Cells. Pharmaceutics, 14(10), 2223.
https://doi.org/10.3390/pharmaceutics14102223